Zheng Quan Ri Bao Zhi Sheng·2025-03-30 12:32Group 1: Financial Performance - Heng Rui Pharmaceutical reported a net profit of 6.337 billion yuan for 2024, a year-on-year increase of 47.28% and proposed a cash dividend of 2.00 yuan per 10 shares [1] - China National Petroleum Corporation achieved a net profit of 164.684 billion yuan in 2024, a 2% increase year-on-year, with a revenue of 2.94 trillion yuan, down 2.5% [1] - Sanofi Biologics expects a net profit of 39.1985 million to 47.9092 million yuan for Q1 2025, representing a year-on-year increase of 137.97% to 190.85% [3] - Wide Great Materials anticipates a net profit of approximately 75 million yuan for Q1 2025, a year-on-year increase of about 1504.79% [5] - Pu Ran Co. reported a revenue of 1.804 billion yuan for 2024, a 60.03% increase year-on-year, and a net profit of 292 million yuan, turning from loss to profit [6] - Xi Zi Clean Energy achieved a net profit of 440 million yuan in 2024, a 705.74% increase year-on-year, despite a revenue decline of 20.33% [10] - Ansteel Group reported a net loss of 7.122 billion yuan for 2024, compared to a loss of 3.255 billion yuan the previous year [12] Group 2: Corporate Actions - China Construction Bank plans to issue A-shares to introduce strategic investment from the Ministry of Finance, with a total fundraising amount not exceeding 105 billion yuan [2] - Postal Savings Bank intends to issue A-shares to the Ministry of Finance, China Mobile Group, and China Shipbuilding Group, raising a total of 130 billion yuan for core tier one capital [7] - Bank of China signed a conditional share subscription agreement with the Ministry of Finance for a total of 165 billion yuan, with a subscription price of 6.05 yuan per share [8] - Huada Jiutian plans to acquire 100% of Chip and Semiconductor through a combination of share issuance and cash payment, enhancing its capabilities in EDA solutions [9] - China Aviation Industry Finance announced the voluntary termination of its stock listing, with shares resuming trading on March 31, 2025 [4]